U.S. biopharmaceutical company Tesaro (TSRO) is discussing its options with investment banks after receiving acquisition interest from several drugmakers, according to people familiar with the

Meredith (MDP) and an investor group led by Edgar Bronfman Jr. have advanced in their pursuit of Time as the publisher explores a possible sale, according

Hudson’s Bay Company (HBC.TO), the Canadian owner of Saks, has approached Macy’s (M) about a potential takeover, people briefed on the matter who were not

Cerulean Pharma (CERU), a clinical-stage company developing nanoparticle-drug conjugates (NDCs), today announced that its Board of Directors is conducting a comprehensive review of strategic alternatives

Frontline (FRO) has approached DHT Holdings (DHT) with a non-binding proposal for a possible business combination where Frontline would acquire all outstanding shares of common